- AMC
- ITI Mutual Fund
- Category
- Sectoral/ Thematic
- ISIN
- INF00XX01BL5
ITI Pharma and Healthcare Fund
₹16.8555
−₹0.1780 (−1.04%)
NAV · Regular · Growth ·
ITI Pharma and Healthcare Fund's Regular Growth NAV was ₹16.8555 on 19 Oct 2026, down 1.04% on the day. Its 3-year return is 15.14% a year.
- Expense ratio
- 2.63%
- Fund size
- ₹233.89 Cr
- Min. investment
- ₹5,000
NAV history
Between 20 Oct 2025 and 19 Oct 2026, the NAV ranged from ₹14.4974 to ₹18.4454.
Regular · Growth plan. 3Y, 5Y and since-launch returns are annualised; since launch is absolute until the fund is a year old. Longer ranges appear once the fund has that much history.
Fund details
- Expense ratio
- 2.63% (Regular)
- Exit load
- 0.50% if redeemed/switched out within 3 months from allotment date; nil thereafter
- Riskometer
- Very high
- Benchmark
- Nifty Healthcare Total Return Index
- Launched
- 18 Oct 2021
- Fund managers
- Nilay Dalal, Animesh Singh
Fund size, expense ratio and minimums as of 16 Oct 2026.
All plans
| Plan | ISIN | NAV | 1 day | Expense ratio | 1 year |
|---|---|---|---|---|---|
| Direct · Growth | INF00XX01BO9 | ₹18.5899 | −1.03% | 0.92% | +4.00% |
| Regular · Growth | INF00XX01BL5 | ₹16.8555 | −1.04% | 2.63% | +2.15% |
| Direct · IDCW | INF00XX01BP6 | ₹18.5878 | −1.03% | 0.92% | +3.99% |
| Regular · IDCW | INF00XX01BM3 | ₹16.8555 | −1.05% | 2.63% | +2.15% |
All plans hold the same portfolio. They differ in expense ratio (Direct plans pay no distributor commission) and in how gains are handled (Growth reinvests, IDCW pays out).
Armor risk check
ITI Pharma and Healthcare Fund moves about as much as the market
Volatility, past year
Worst fall, past year
Compared with the Nifty 500 over the past 12 months.
Check it against your portfolio in the appAbout this fund
ITI Pharma and Healthcare Fund is an open-ended mutual fund from ITI Mutual Fund, in the Sectoral/ Thematic category. It began on 18 Oct 2021. It is benchmarked to the Nifty Healthcare Total Return Index. The fund manages ₹233.89 Cr across its plans as of 16 Oct 2026. The Regular · Growth plan has an expense ratio of 2.63%. The minimum first investment is ₹5,000, and SIPs are available.
FAQs
What is the NAV of ITI Pharma and Healthcare Fund?
The NAV of ITI Pharma and Healthcare Fund (Regular · Growth) was ₹16.8555 on 19 Oct 2026, down 1.04% from the previous NAV.
What plans does ITI Pharma and Healthcare Fund have?
ITI Pharma and Healthcare Fund has 4 plans: Direct · Growth; Regular · Growth; Direct · IDCW; Regular · IDCW.
What is the expense ratio of ITI Pharma and Healthcare Fund?
The Regular · Growth plan of ITI Pharma and Healthcare Fund has an expense ratio of 2.63%.
What is the fund size (AUM) of ITI Pharma and Healthcare Fund?
ITI Pharma and Healthcare Fund manages ₹233.89 Cr across all plans as of 16 Oct 2026.
What returns has ITI Pharma and Healthcare Fund delivered?
ITI Pharma and Healthcare Fund returned +2.15% over 1Y, +15.14% a year over 3Y. Past performance does not guarantee future returns.
What is the exit load of ITI Pharma and Healthcare Fund?
ITI Pharma and Healthcare Fund: 0.50% if redeemed/switched out within 3 months from allotment date; nil thereafter.
What is the minimum investment and SIP amount for ITI Pharma and Healthcare Fund?
The minimum first investment in ITI Pharma and Healthcare Fund is ₹5,000, and ₹1,000 after that. SIPs are available (SIP available Daily/Weekly/Monthly with minimum Rs. 500-1000, minimum 6-30 instalments depending on frequency).
How risky is ITI Pharma and Healthcare Fund?
ITI Pharma and Healthcare Fund is rated "very high risk" on SEBI's riskometer.
For information only. Not investment advice or a research report. Past performance does not guarantee future returns. Mutual fund investments are subject to market risks; read all scheme-related documents carefully.
Full disclaimerSee how ITI Pharma and Healthcare Fund fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app